ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Varta AG

Varta AG (VAR1D)

2.038
-0.296
( -12.68% )
Updated: 10:21:20
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.038
Bid
2.054
Ask
2.086
Volume
46,510
1.912 Day's Range 2.266
0.00 52 Week Range 0.00
Previous Close
2.334
Open
2.266
Last Trade
22
@
2.038
Last Trade Time
10:09:12
Average Volume (3m)
-
Financial Volume
97,878 €
VWAP
2.1045

VAR1D Latest News

Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase

MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and...

Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals

Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio  MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta...

Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company

MORRISTOWN, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (the “Company” or “Melinta”), a commercial-stage company focused on the development and commercialization of novel...

Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures

Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company...

Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility

MORRISTOWN, N.J., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT) (the “Company” or “Melinta”), a commercial-stage company focused on the development and...

Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019

MORRISTOWN, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...

~ Approval Based on Positive Phase III Trial Results of BAXDELA for Treatment of CABP in Adults~ ~ Company Delays Launch of CABP Indication Until Further Visibility Into Liquidity Position ~...

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 52 Presentations by Coalition Members During the Annual Meeting PR Newswire WASHINGTON, Oct. 1, 2019...

Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director

MORRISTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (Nasdaq: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics...

Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan

MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ISOFOSIsofol Medical AB
SEK 2.77
(56.85%)
73.87k
AG1DAUTO1 Group
7.885 €
(15.28%)
54.27k
TMVDTeamViewer SE
12.355 €
(12.78%)
63.33k
HEXOHexagon Composites ASA
kr 33.20
(11.97%)
33.06k
EAPIPEuroapi SA
3.734 €
(10.60%)
22.78k
LOCALPSolocal Groupe
0.0035 €
(-35.19%)
11.18M
2HRADH & R GmbH & Co
4.10 €
(-18.33%)
197
EBUSAEbusco Holding NV
1.173 €
(-18.09%)
37.77k
RENERenta Corp Real Estate SA
0.768 €
(-13.90%)
600
VAR1DVarta AG
2.038 €
(-12.68%)
46.51k
LOCALPSolocal Groupe
0.0035 €
(-35.19%)
11.18M
TITMTelecom Italia SpA
0.2266 €
(-1.48%)
2.34M
ISPMIntesa Sanpaolo Spa
3.7425 €
(-1.43%)
2.07M
BBVAEBanco Bilbao Vizcaya Argentaria SA
9.758 €
(-4.29%)
1.56M
CABKECaixaBank SA
5.382 €
(-0.81%)
1.53M

Discussion

View Full Feed
Iggy_Bot Iggy_Bot 2 minutes ago
Take it out of there pay..
VikingInvest VikingInvest 2 minutes ago
I am not sure what the rules are for a private transfer of equities. I would assume it is different from a public sale, but I don’t know.
NWBO
johnlconfer johnlconfer 2 minutes ago
AZ funny thought Gold average price in 2008 $872! Today Gold price is $2468!

Semper Fi
COOP
gdog gdog 2 minutes ago
yup I just hope it happens in time for me to see it. rotflol
NLST
getmoreshares getmoreshares 3 minutes ago
more bids- two brokers at .22
BLFR
peterus peterus 3 minutes ago
did some dd think this will get taken over
BFI
Viewmont Viewmont 3 minutes ago
Accumulation is going on! https://x.com/Prince_Cali_619/status/1818653566317339112
HIRU
StockItOut StockItOut 3 minutes ago
22.16M HMNY traded this year. High was $0.0004. Most was traded at 0.000001.

Even if all 22.16M HMNY shares traded at $0.0004, would be just $8,864 traded in all of 2024.

There's no market. Nothing here.

Good luck. Comparison to S&P is silly.
HMNY
ignatiusrielly35 ignatiusrielly35 3 minutes ago
I’ll believe it when I see it. All they ever crow about is production improvements and the gross margin. The revenue growth has been abysmal, requiring incessant dilution. And it ain’t over yet. This is the reason for the pathetic share price.
NEXCF
Birdbrain Ideas Birdbrain Ideas 4 minutes ago
I hope that's true, but wouldn't Amarin have emphasized that during the conference call? And if it's true and they did not mention it, that's pretty pathetic from a PR perspective.
AMRN
jog49 jog49 4 minutes ago
"Think long term. The more they earn, the more capital they’ll have when this swindle ends."

I'm a bit more concerned if I will have anything to show before I die of old age. Screw the children and grandchildren, I want what I've waited for going on 20 years now! This stock was $57+ w
FNMA
Nebuchadnezzar Nebuchadnezzar 4 minutes ago
apparently BOTY is working on a film

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174838336
BOTY
BadaBingPebble BadaBingPebble 4 minutes ago
You may want to wait for the next few share updates before being Bullish lol. Henry has his usual messengers out there lately spreading the word of more money being needed for "fees" again. He also Tweeted last week which usually has hidden meaning.

Some of the volume lately looks ex
PHIL
SkeBallLarry SkeBallLarry 4 minutes ago
" YES, they did " .. !! . Will cost more now " .. !!
FeMike FeMike 4 minutes ago
But even given this comprehensive coverage, they said that they could not confirm the efficacy of DCVAX-l, as they merely had just, verbatim, printed what Professor Ashkan had sent them.

This email to me, from this Charity is in my archive.

So you're saying that the BTC
NWBO
Here Today Here Today 4 minutes ago
No it was actually very good results from the CT Phase 0.
RNAZ
Bayguy Bayguy 4 minutes ago
I appreciate your posts Savannah-Marc. $RONN$ Long
RONN
MartinLutherKing MartinLutherKing 4 minutes ago
Gearing up fo the dolla
FOXO
Monroe1 Monroe1 4 minutes ago
Mornin All. Pouring coffee into my Amor 4 Us liquid metal cup...wish it was.
Should we soon start producing more of the ring thing? Looks like it will happen.

Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
LQMT
Here Today Here Today 5 minutes ago
This is the one that needs to start recruiting and now!!!!


https://clinicaltrials.gov/study/NCT06260774
RNAZ
ANTI-BAGHOLDER ANTI-BAGHOLDER 5 minutes ago
Yeah. Go research this guy. He has 22 comments on his announcement of working with Indexr.

https://www.linkedin.com/posts/dforrester_excited-to-share-that-im-starting-a-new-activity-7224418020033540097-wGwG?utm_source=share&utm_medium=member_ios
MONI
vanwest vanwest 5 minutes ago
Yes I have bought and have been patiently waiting for big news to move this stock.
ECSL
Savannah-Marc Savannah-Marc 5 minutes ago
RONNN TSUNAMI!!! RIDE THE WAVE!!!
RONN
mick mick 5 minutes ago
I HOPE 45 CAN MAKE IT. SAID POSSIBLE RE; CAN HAPPEN AGAIN.